NKGN
NKGen Biotech Inc

1,185
Mkt Cap
$2.61M
Volume
225.00
52W High
$0.9649
52W Low
$0.0002
PE Ratio
-0.01
NKGN Fundamentals
Price
$0.021
Prev Close
$0.021
Open
$0.021
50D MA
$0.0489
Beta
4.98
Avg. Volume
8,293.52
EPS (Annual)
-$1.54
P/B
-0.01
Rev/Employee
$0.00
Loading...
Loading...
NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company was founded by Sangwoo Park in 2017 and is headquartered in Santa Ana, CA.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
26

Frequently Asked Questions

What is Market Cap of NKGen Biotech Inc?
What is the 52-week high for NKGen Biotech Inc?
What is the 52-week low for NKGen Biotech Inc?
What is NKGen Biotech Inc stock price today?
What was NKGen Biotech Inc stock price yesterday?
What is the PE ratio of NKGen Biotech Inc?
What is the Price-to-Book ratio of NKGen Biotech Inc?
What is the 50-day moving average of NKGen Biotech Inc?
How many employess does NKGen Biotech Inc has?

Latest NKGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.